Porphyrin-lipid assemblies and nanovesicles overcome ABC transporter-mediated photodynamic therapy resistance in cancer cells
Yan Baglo(University of Maryland, College Park), Huang‐Chiao Huang(University of Maryland, Baltimore), Michael M. Gottesman(National Institutes of Health), Robert W. Robey(National Cancer Institute), Suresh V. Ambudkar(National Institutes of Health), Barry J. Liang(University of Maryland, College Park)
Cited by 60
Related Papers
Cisplatin Resistance: A Cellular Self-Defense Mechanism Resulting from Multiple Epigenetic and Genetic Changes
|Pharmacological Reviews|2012|968
Inorganic nanoparticles for cancer imaging and therapy
|Journal of Controlled Release|2011|599
Lapatinib (Tykerb, GW572016) Reverses Multidrug Resistance in Cancer Cells by Inhibiting the Activity of ATP-Binding Cassette Subfamily B Member 1 and G Member 2
|Cancer Research|2008|385
Immunological and Toxicological Considerations for the Design of Liposomes
|Nanomaterials|2020|357
Breaking the selectivity-uptake trade-off of photoimmunoconjugates with nanoliposomal irinotecan for synergistic multi-tier cancer targeting
|Journal of Nanobiotechnology|2020|327